about
Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspectsThe views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescriptionAssociations Between Personality Traits and Adherence to Antidepressants Assessed Through Self-Report, Electronic Monitoring, and Pharmacy Dispensing Data: A Pilot Study.Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.Signs and symptoms indicative of potential adverse drug reactions in homecare patients.Linking laboratory and medication data: new opportunities for pharmacoepidemiological research.Drug-induced thrombocytopenia: a population study.Platelet measurements versus discharge diagnoses for identification of patients with potential drug-induced thrombocytopenia: a cross-sectional study in the Netherlands.Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.Discriminative value of platelet size indices for the identification of the mechanism of chemotherapy-induced thrombocytopenia.Rituximab-induced thrombocytopenia: a cohort study.The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review.Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital.Oral medicines for children in the European paediatric investigation plans.Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT projectDrug-related problems in hospitalised patients.Quantifying antibiotic use in paediatrics: a proposal for neonatal DDDsRisk factors for the development of lithium-induced polyuria.Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT.The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study.Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase.Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.Does the length of the first antidepressant treatment episode influence risk and time to a second episode?A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.The association between prescription change frequency, chronic disease score and hospital admissions: a case control study.Practical problems with medication use that older people experience: a qualitative study.Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study.Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia.Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugsThe availability and age-appropriateness of medicines authorized for children in The Netherlands.Task analysis of information technology-mediated medication management in outpatient care.Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.Adherence with Dosing Guideline in Patients with Impaired Renal Function at Hospital DischargeMEDUCATE trial: effectiveness of an intensive EDUCATional intervention for IT-mediated MEDication management in the outpatient clinic - study protocol for a cluster randomized controlled trial.Incidence and determinants of long-term use of antidepressants.Association between antidepressant drug use and hyponatraemia: a case-control study.
P50
Q28079594-FA6DE026-2C49-4537-8F29-E27665CDEA6EQ28535398-C9248534-77BF-4FF7-836B-8E486064104DQ31117309-23F71175-E9D2-4A2D-BDE0-C1047BB12661Q31143760-D24850B5-44E1-4B99-8133-B9AFAD86E0F7Q33162113-402CBD88-FFC8-414C-A621-1DB68B2AEBA0Q33163574-6E3EDC6E-C7DD-4B1F-A778-062FD8DC1785Q33270070-5D568519-793A-422B-9473-A4C2A2C9121DQ33372085-38C9E31E-1F70-4019-AB41-B86615AA2133Q33382726-A56E7E77-4B42-4FF1-9998-7FB3CEDF962BQ33385883-8839A602-5B3A-4AD9-917E-456A17C71136Q33392464-12011E80-DB51-41E8-AE2B-C941712C8FCBQ33401452-ECA2750B-C458-401B-8FF7-401871D9E778Q33425099-F34B8473-EE06-4E49-B9FE-855F99F8D0CDQ33516030-CC4E3F61-4D81-4D98-AD00-6D95E880440EQ33606014-740000FC-E35F-463A-A917-2EF00F102FDCQ33711893-13D613E8-A062-44ED-807E-33EA9E48C2D1Q33851671-49737237-7C99-4443-B31B-871516C3A277Q33903082-FDAB9C66-31B7-474C-82B8-932DEF743558Q34118024-B2AE9B82-3430-48AE-B5F6-F7E6E6E54827Q34187370-6FC85693-28AF-4DE0-BCCB-9C5356E3A7A2Q34188962-21BE6C05-5264-4FB0-820A-F6AE3DD26EDBQ34407111-8AD81210-2B1A-4AA8-8FCB-178EB1ED7273Q34507149-712FAF8D-CBBB-4EF6-9A48-265063C473AAQ34552779-6297F57B-7FD5-431C-A254-9A90BBF769F0Q34557821-D3610ACA-3B48-4914-9EFC-0B8958E84A03Q34603065-B2CE3D43-92B2-4F4B-8A8A-3A284FBD32F1Q34629802-B526E64E-DC2F-4B11-A8D1-304891C43433Q34895282-53B20C5F-ED7C-40F7-BFCC-B3D728E2F521Q34942492-0055568D-A6DF-4B35-9A0B-8C5F0ED30FCAQ34999668-4DF6AC1B-C979-40A2-B5AA-488C54FBE372Q35036312-ECDA430E-80CB-440E-9F8E-A8DA068419E2Q35158709-242C1C67-7F8F-4D1B-ADA0-C00AFDDAA1ADQ35219667-E37F33C5-33D6-419B-949E-FC2180051FD7Q35574044-8445BCDA-2069-43A3-8766-B3ADE86D4E6BQ35582724-93B55F23-3C29-46D5-A348-0D7E13EA8F60Q35644029-7E70D3DE-E7D4-450B-B3F1-EC9CE1C5E3E3Q35656596-40EF5E3C-82D0-4B8C-BF74-A88154E3A2B0Q35659219-E742261E-DE93-496C-B1DC-8EE895421E7BQ35676317-B3B4DA60-3251-4D95-A9A1-31B66C63A97EQ35803582-3FB9BEFB-08D7-4834-B5F8-02C9C3C2EA76
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Toine Egberts
@ast
Toine Egberts
@en
Toine Egberts
@es
Toine Egberts
@nl
type
label
Toine Egberts
@ast
Toine Egberts
@en
Toine Egberts
@es
Toine Egberts
@nl
altLabel
Egberts AC
@en
prefLabel
Toine Egberts
@ast
Toine Egberts
@en
Toine Egberts
@es
Toine Egberts
@nl
P1053
A-6625-2012
P106
P1153
7004571941
P21
P31
P496
0000-0003-1758-7779